Literature DB >> 21889207

Defining fetal growth restriction in mice: A standardized and clinically relevant approach.

M R Dilworth1, L C Kusinski, B C Baker, L J Renshall, S L Greenwood, C P Sibley, M Wareing.   

Abstract

The increasing number of mouse models of fetal growth restriction (FGR) make it crucial to standardize the way FGR is defined. By constructing growth curves in the placental-specific Igf2 knockout mouse (P0) it was demonstrated that 93% of P0 fetuses fell below the 5th centile of wild-type weights at E18.5, up from 44% at E16.5. This analysis, coupled with anthropomorphic measurements showing evidence of head sparing in P0 fetuses, allows clinical comparisons of FGR in mice through the use of clinically relevant growth curves. We suggest this as a standardized approach to defining FGR in mouse, and other animal models. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21889207     DOI: 10.1016/j.placenta.2011.08.007

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  21 in total

1.  Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype.

Authors:  Mark Robert Dilworth; Irene Andersson; Lewis James Renshall; Elizabeth Cowley; Philip Baker; Susan Greenwood; Colin Peter Sibley; Mark Wareing
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

2.  Early onset intrauterine growth restriction in a mouse model of gestational hypercholesterolemia and atherosclerosis.

Authors:  Dolores Busso; Lilian Mascareño; Francisca Salas; Loni Berkowitz; Nicolás Santander; Alonso Quiroz; Ludwig Amigo; Gloria Valdés; Attilio Rigotti
Journal:  Biomed Res Int       Date:  2014-09-10       Impact factor: 3.411

3.  Chronic Protein Restriction in Mice Impacts Placental Function and Maternal Body Weight before Fetal Growth.

Authors:  Paula N Gonzalez; Malgorzata Gasperowicz; Jimena Barbeito-Andrés; Natasha Klenin; James C Cross; Benedikt Hallgrímsson
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

4.  Expression of epigenetic machinery genes is sensitive to maternal obesity and weight loss in relation to fetal growth in mice.

Authors:  Polina E Panchenko; Sarah Voisin; Mélanie Jouin; Luc Jouneau; Audrey Prézelin; Simon Lecoutre; Christophe Breton; Hélène Jammes; Claudine Junien; Anne Gabory
Journal:  Clin Epigenetics       Date:  2016-02-27       Impact factor: 6.551

5.  Tumor-homing peptides as tools for targeted delivery of payloads to the placenta.

Authors:  Anna King; Cornelia Ndifon; Sylvia Lui; Kate Widdows; Venkata R Kotamraju; Lilach Agemy; Tambet Teesalu; Jocelyn D Glazier; Francesco Cellesi; Nicola Tirelli; John D Aplin; Erkki Ruoslahti; Lynda K Harris
Journal:  Sci Adv       Date:  2016-05-06       Impact factor: 14.136

6.  Crossing mice deficient in eNOS with placental-specific Igf2 knockout mice: a new model of fetal growth restriction.

Authors:  M R Dilworth; L C Kusinski; B C Baker; L J Renshall; P N Baker; S L Greenwood; M Wareing; C P Sibley
Journal:  Placenta       Date:  2012-10-23       Impact factor: 3.481

7.  In vitro assessment of mouse fetal abdominal aortic vascular function.

Authors:  Lewis J Renshall; Mark R Dilworth; Susan L Greenwood; Colin P Sibley; Mark Wareing
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-23       Impact factor: 3.619

8.  The atrial natriuretic peptide (ANP) knockout mouse does not exhibit the phenotypic features of pre-eclampsia or demonstrate fetal growth restriction.

Authors:  Sarah L Finn-Sell; Lewis J Renshall; Elizabeth J Cowley; Mark R Dilworth; Mark Wareing; Susan L Greenwood; Colin P Sibley; Elizabeth C Cottrell
Journal:  Placenta       Date:  2016-04-06       Impact factor: 3.481

Review 9.  Placental Adaptation: What Can We Learn from Birthweight:Placental Weight Ratio?

Authors:  Christina E Hayward; Samantha Lean; Colin P Sibley; Rebecca L Jones; Mark Wareing; Susan L Greenwood; Mark R Dilworth
Journal:  Front Physiol       Date:  2016-02-05       Impact factor: 4.566

10.  The impact of a human IGF-II analog ([Leu27]IGF-II) on fetal growth in a mouse model of fetal growth restriction.

Authors:  Jayne C Charnock; Mark R Dilworth; John D Aplin; Colin P Sibley; Melissa Westwood; Ian P Crocker
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-11-03       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.